Johnson Controls International (JCI) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
8 Jun, 2026Executive summary
Q1 2025 sales rose 4% to $5.43B, with organic sales up 10% year-over-year; adjusted EPS increased 39% to $0.64, and GAAP EPS was $0.55.
Orders grew 16% organically, with backlog reaching a record $13.2B, supporting sustained growth across all business segments.
Announced CEO succession, with Joakim Weidemanis to succeed George Oliver in March, and continued transformation to a pure-play commercial building solutions provider.
Launched a multi-year restructuring plan targeting $400M in costs and $500M in annual savings, with most stranded cost benefits expected in FY26.
Entered a definitive agreement to sell the Residential and Light Commercial HVAC business for $8.1B, with closing expected in Q4 FY25.
Financial highlights
Gross profit increased 8% year-over-year to $1.93B, with gross margin improving to 35.5%.
Adjusted EBIT rose 28% to $568M; adjusted net income from continuing operations increased 35% to $424M.
Adjusted EPS was $0.64, up nearly 40% year-over-year, exceeding guidance by $0.04.
Adjusted free cash flow was ~$600M, improving nearly $800M year-over-year; adjusted free cash flow conversion at 143%.
Ended Q1 with $1.2B in available cash; net debt at $8.76B and net debt/EBITDA at 2.3x, within target range.
Outlook and guidance
Raised full-year FY25 guidance: organic sales growth in mid-single digits, adjusted segment EBITA margin to expand over 80 bps, and adjusted EPS of $3.50–$3.60 (9–12% growth).
Q2 2025: Organic sales growth expected in mid-single digits, adjusted segment EBITA margin ~16.5%, and adjusted EPS $0.77–$0.79.
Free cash flow conversion targeted at 90%+ for FY25.
Proceeds from R&LC HVAC sale expected to be $5B after-tax, to be used for debt reduction and share repurchases.
Company expects to maintain investment grade rating and continue dividend payments through FY25.
Latest events from Johnson Controls International
- Q3 delivered growth, margin expansion, record backlog, and major divestitures amid portfolio shift.JCI
Q3 20248 Jun 2026 - Q4 organic sales up 10%, margin expansion, record backlog, and strong FY25 outlook.JCI
Q4 20248 Jun 2026 - Q2 2025 saw 7% organic sales growth, margin expansion, and raised FY25 guidance.JCI
Q2 20258 Jun 2026 - Q3 saw 6% organic sales growth, record backlog, and expanded share repurchase authorization.JCI
Q3 20258 Jun 2026 - Record backlog, strong execution, and robust capital returns set up double-digit EPS growth in 2026.JCI
Q4 20258 Jun 2026 - Sales, EPS, and backlog hit records, with raised FY26 guidance and strong demand across regions.JCI
Q1 20268 Jun 2026 - Q2 saw 8% sales growth, 45% adjusted EPS growth, and record backlog, prompting raised guidance.JCI
Q2 20268 Jun 2026 - Innovation and operational excellence drive high single-digit organic growth and service expansion.JCI
Analyst Day 20265 Jun 2026 - Strong order growth, margin gains, and strategic focus drive optimism for future performance.JCI
19th Annual Global Transportation & Industrials Conference20 May 2026